SHENZHEN, Sept 24, 2024 - (ACN Newswire) - China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased...
Hospital Authority and Chinese Academy of Medical Sciences jointly organised 2024 Forum on Frontiers in Medical Sciences among Mainland, Taiwan, Hong Kong and Macao...
Leading STEM-focused children's supplemental education company, Little Medical School, has signed their master franchisee for Ontario and is now growing its franchise program throughout...
RESULTS HIGHLIGHTS
The Group’s revenue amounted to HK$1,393.3 million, supported by the pickup in consumption momentum and the contribution from new shops in both Hong...
Innovative drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets (Lumeblue®) is an oral diagnostic drug, approved by China’s NMPA for enhancing visualisation of colorectal lesions in...
Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney disease patients. The Product is administrated orally, thus expecting to...